26 | IBRUTINIB‐RITUXIMAB VERSUS PLACEBO‐RITUXIMAB IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA (FL): PRIMARY ANALYSIS OF THE PHASE 3 PERSPECTIVE STUDY | Publicación